Universitat de Lleida   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Lleida Spain (1300)

Organization Overview

First Clinical Trial
2011
NCT01347515
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Universitat de Lleida | Universitat se Lleida

Active Ingredients

Drugs in Phase 4 Trials (1)

calcitriol (rocaltrol) (1 trial)

Drugs in Phase 3 Trials (1)

colchicine (colbenemid) (1 trial)

Drugs in Phase 2 Trials (1)

olive (1 trial)

Drugs in Phase 1 Trials (1)

ginseng (1 trial)

Drugs in Other Trials (4)

cellulose (1 trial)

fibracep (1 trial)

psyllium (1 trial)

wheat (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Inflammation (Phase 3)

Ischemic Attack, Transient (Phase 3)

Stroke (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 6
  • # of Trial APIs: 8